Recursion Pharmaceuticals 
RXRX is looking at a strong bullish bottoming out after the stock saw strong break out of the falling wedge and the breaking out of the small range at the 2nd bottom of the larger double bottom. Volume surge and reiterate the buying pressure.
Mid-term stochastic oscillator is showing oversold crossover and 23-period roc is rising and is clearing above the zero line. Meanwhile, IChimoku's 9-period conversion and 26-period base line is showing early signs of bullish crossover
RXRX is looking at a strong bullish bottoming out after the stock saw strong break out of the falling wedge and the breaking out of the small range at the 2nd bottom of the larger double bottom. Volume surge and reiterate the buying pressure. Mid-term stochastic oscillator is showing oversold crossover and 23-period roc is rising and is clearing above the zero line. Meanwhile, IChimoku's 9-period conversion and 26-period base line is showing early signs of bullish crossover
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。